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COVER William G. Powderly, MO, holds a colorful 
assortment of pills, which in various combinations make 
up the "cocktail," the therapy which has proven to be 
a lifeline for many people infected with HIV (green 
model). He and his colleagues at the School of Medicine's 
AIDS Clinical Trials Unit (ACTU) help patients manage 
the disease, while holding out hope for better treatments. 
The potent drug mixture allows people to live longer and 
healthier lives, yet its long-term consequences are just 
beginning to be understood. Examining the cocktail's 
powerful effect on the body is becoming a focus of AIDS 
research. For more on this story, please turn to page 12. 
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FEATURES 
I Can See Clearly Now BY CANDACE O'CONNOR 
An exci ting new therapy aJlows some older adults with 
age-related eye disease to regain vision and independence. 
The Cocktail Conundrum BY GILA Z. RECKESS 
The much-lauded drug "cocktail" enables persons with 
A1DS to live longer, healthier lives-but at what cost? 
The Immune System vs. Tumors BY GILA Z. RECKESS 
Linking immunology and oncology, researchers find 
the immune system plays a role in tumor formation. 
Smile Doctor BY DAVID LINZEE 
Providing pediatric dentistry for specia l-needs kids 
is a prioriry and a pleasure for one faculry member. 
26 Surgeon and urologist 
Richard A. Blath, MD, with 
third-year medical student 
Caitlin Aveyard 
US. News &World Report 
rankings of medical schools 
and their programs 
Academy elects Gordon as member 
JEFFREY r. GO RDON, MD , the Alumni Professor 
and h ead of molecular biology and pharmacology, 
was one of 72 new members elected to the National 
Academy of Sciences on May 1, 200 1. Election to the 
academy is considered one of the highes t honors that 
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can be bestowed on an 
American scien tist or 
engineer, and its members 
are chosen in recognition 
of their distinguished and 
con tinuing achievements 
in original research. 
Gordon is known for his 
resea rch on gastro intestinal 
development and how gut Jeffrey I. Gordon, !VI D 
bac teria affec t normal intes­
tinal function and pred ilection to certain diseases. His 
research may help scientists understand such commo n 
human diseases as inflammatory bowel di sease, irritable 
bowel syndrome and stomach ulcers. 
In addition, Gordon's lab has studied an enzyme, 
N-myristoyltransferase, that affec ts the funct ions of 
m any cellular proteins and is requ ired for the survival 
of fun gi that cause systemic infections in humans with 
compromised immune sys tems. 
Gordon also is director of the Divi sio n of Biology 
and Biomedica l Sciences, wh ich oversees all PhD and 
MD/PhD students in the biological sciences, and has 
mentored more than 60 young researchers. 
Boxerman assumes leadership of HAP 
STUART B. BOXERMAN, DSC, has been named 
director of the Health Administration Program at the 
School of Medicine. He had been serving as interim 
director of the program since July 2000, followi ng the 
re tirement of James O. Hepner, PhD. 
Boxerman ea rned three degrees from Washington 
Unive rsiry. Two were in engineering-a bachelor's degree 
in 1963 and a master's degree in 1965. In 1970, he was 
awarded his doctorate in applied mathematics and 
computer sCience. 
The Health Ad ministrati on Program, founded in 
1946, provides its students with a firm foundation in 
management integrated with a solid understanding of 
the health care field and its current delivery systems. 
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Gelberman named AAOS president 
RICHARD H. GELBERMAN, MD, the Fred C. Reynolds 
Professor and head of orthopaedic surgery, recently became 
presidenc of the 25,500-member American Academy of 
Orchopaedic SurgelY (AAOS) at its 68th annual meeting 
and scientific sess ions in San Francisco CA. 
A mem ber of the academy since 1981, Gelberman 
has served on more than a dozen of its committees and 
task fo rces. Most recently, he had been one of the organi­
za tion's vice presidents. As president, he plans to initiate 
a new program designed to improve musculoskeletal care 
for the public through better education for doctors. 
Gelberman also is chief of hand and wrist surgery 
and director of the hand and upper extremity fellowship 
traini ng program at the School of Medicine, and is 
orthopaedic-surgeon-in-chief at Barnes-Jewish and 
St. Louis Children's hospitals. 
H e has had support from 
the N ational Institutes of 
H ealth for his research on 
dense regular connective tis­
sue since 1976. He also has 
research interests in radius 
fractures, ca rpal instabili ty 
and nerve injuries. 
Gelberman is the author 
Richard H. Gelberman, MD of more than 200 scientific 
............................................. ....... man uscripts and has received 
many awards for his research. He has served on the edito­
rial boards of several medical publications, and currently 
serves as a reviewer for the Journal of Bone and Joint 
Surger)1 and the Journal ofOrthopaedic Research. 
The AAOS is a no t-for-profit organization that 
provides education programs for orthopaedic surgeons, 
allied health professionals and the public. 
NEUROLOGY 
Mild cognitive impairment appears to be Alzheimer'S disease 
OST PEOPLE DIAGNOSED with mild 
cognitive impairment (Mel) evenrualJy 
develop Alzheimer's disease, researchers with 
the School of Medicine's Memory and Aging 
Project (MAP) have found. The results suggest that Mel, 
characterized by minor memory loss, is an early stage of 
Alzheimer's rather than a separate disorder. 
that the subtle signs of memory loss might indicate the 
onset of Alzheimer's disease. 
The volunteers were reassessed annually for up to 
9.5 years. After five years, Alzheimer symptoms had 
developed in 6.8 percent of the healthy volunteers, 
19.9 percent of the individuals in the uncertain MCl 
group, 35.7 percent of those in the suspicious group and 
"We were surprised to find that an 60.5 percent of those in the fairly 
unexplained memory deficit that is cur­ confident group. By 9.5 years. all of 
rendy called MCl almost always turns the volunteers with the most severe 
out to be early Alzheimer's," says John form ofrvlCl had developed the 
C. Morris, MD, Harvey A. and clinical symptoms of Alzheimer's. 
Dorismae H acker Friedman Professor Forry-two participants died before 
of Neurology, director of MAP and the end of the srudy and donated 
co-director of the Alzheimer's Disease their brains for postmortem analysis, 
Research Center. He is first author of a the only way to diagnose Alzheimer's 
paper on the subject that appeared in disease with complete accuracy. 
the March issue ofArchives ofNeurology. Autopsies of 25 volunteers who origi­
nally were diagnosed with MCIResearchers examined 404 people 
who had either mild memory loss or no memory prob­
lems and who volunteered for annual memory assess­
ments at MAP between July 1990 and June 1997. The 
227 individuals with MCI were placed into one of three 
categories: fairly confident, suspicious and uncertain. The 
categories reAected the researchers' degree of confidence 
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confirmed that 21 had Alzheimer's disease. 
Morris points out that these results are based on a 
select group of individuals who volunteered for memory 
research. "Even with that caveat, the findings are impres­
sive," he says. Earlier diagnosis will help scientists develop 
more etTective therapies for early intervention. 
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The mission of FASEBTeitelbaum is FASER president-elect 
is ro en hance che abili ry of 
STEVEN L. TEITELBAUM, MD, has been selected as biomedical and life sciemiscs 
the nexc presidenr-elect of the Federation ofAmerican ro improve, through cheir 
Sociecies for Experimencal Biology (FASEB), effeccive research, the healch, well­
July 1, 2001. FASEB is che largest coaJicion of biomedical being and productivity of 
research associations in che United States, represeming all people. The organization 
21 sociecies wich more chan 60,000 members. serves the imerests of these 
Teicelbaum, who is che Wilma and Roswell Messing sciemists, particularly in 
Professor of Pathology, will serve as che group's president areas related to publ ic policy. 
in 2002-2003. Also a pathologist ac Barnes-Jewish The group also facilitaces coalicion activi ties among 
Hospital and Sc. Louis Shriners HospitaJ, Teitelbaum member societies and di sseminaces information on 
sets a primary goal in his new role to promoce federal biological research through scientific conferences and 
funding of biomedical and life sciences research. publications. 
PHARMACOGENETICS 
Drug resistance found to vary by ethnicity 
Steven l. Teitelbaum, MD 
Aenetic mutation affecting resistance to chemotherapy occurs more fre­quently in some ethnic groups than 
in others, according to a new study. 
Researchers found that African and 
African-American populations included 
more individuals with the drug-resistant 
gene than Caucasian or Asian popula­
tions. This might help explain why 
some people of African descent 
respond poorly to chemotherapy. 
The research was presented March 
25, 2000, at the annual meeting of 
the American Association for 
Cancer Research in New Orleans. 
"We now know that the genetic 
influence on drug resistance is not 
the same throughout the whole popula­
tion," says Howard L. McLeod, PharmO, 
associate professor of medicine, of phar­
macology and molecular biology and of 
genetics. "Because of this work, we can 
try to solve the problem:' 
McLeod, who led the international 
team of researchers from his previous 
position at the University of Aberdeen in 
the United Kingdom, specializes in phar­
macogenetics, an emerging research field. 
Margaret-Mary Ameyaw, MO, PhD, of the 
University of Aberdeen, is the study's first 
author and will join the Washington 
University faculty later this year. 
The mutation studied by McLeod 
and his colleagues changes production of 
a protein called P-glycoprotein, or PGP, a 
molecular pump that rids cells of drugs. 
When working correctly, PGP pumps 
chemotherapeutic drugs out of tumors, 
allowing the tumor cells to survive. This 
response is known as drug resistance. 
The genetic mutation means the PGP 
pump stops working, allowing drugs to 
enter and kill tumor cells. 
Working with collaborators in five 
countries, McLeod and his colleagues did 
DNA tests on blood samples from 1,280 
people from 10 ethnic populations. They 
found that some populations were sig­
nificantly more likely than others to 
contain the mutation. The groups of 
African descent-Ghanaian, Kenyan, 
African American and Sudanese­
had the mutation significantly less 
frequently than Caucasian and Asian 
populations tested. 
Because lack of the mutation 
is associated with higher expression 
of PGP and thus higher drug resistance, 
these findings mean that physicians may 
soon have the necessary tools for individu­
alizing therapy, especially for people of 
African heritage. Extreme interventions, 
such as gene therapy, would not be 
necessary because an existing medication 
that chemically inhibits the PGP protein 
could be given to people found to 
overexpress PG P. 
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Students, faculty receive Academic Women's Network 2001 awards 

THREE STUDENTS AND TWO PROFESSORS 
recently were recognized for their achievements by the 
university's Academic Women's Network (AWN). 
Each year, the AWN recognizes graduating students 
in either the MD or PhD programs at the medical 
school based upon their demonstrated outstanding lead­
ership in service ro or advancement of women within the 
community. This year's Student Leadership Awards went 
to Leah Bernstein, PhD, Emily Cronbach, MD, and 
Alison Stuebe, MD. 
Bernstein published two I1rst-author publications 
and contributed ro a third during her graduate work in 
neuroscience. Her thesis project focused on the localiza­
tion and regulation of the so-called RGS proteins or 
Regularors of G protein Signaling. Additionally, she has 
been active in neuroscience education and in student 
government. 
Cronbach is a summa cum laude graduate of 
San Francisco State, with a bachelor's degree in 111m. 
Prior ro entering medical school, she worked on several 
documentaries related to teenagers and HIV. She was the 
co-organizer of the Reproductive Options Education 
program, a forum for debate on ethical issues in repro­
ductive health, and she served as co-coordinator of the 
student chapter of the American Medical Women's 
Association (AMWA) , through which she developed a 
fourth-year elective in outpatient women's health. She 
was selected for Alpha Omega Alpha, the national 
medical honor society. 
Stuebe is a summa cum laude graduate of Duke 
University who came to Washington Universiry after 
a st int as producer for the New York Times online site 
on women's health. She was awarded the School of 
Medicine's Mr. and Mrs. Spencer T. Olin Fellowship for 
Women, and also was selected for Alpha Omega Alpha. 
Stuebe was instrumental in creating the School of 
Medicine's career counseling web site, which she pre­
sented at the 1999 American Association of Medical 
Colleges (AAMC) national meeting. She was active as 
co-coordinator of the student chapter of AMWA, and 
served on the group's national web site task force. 
The AWN presented its 2001 Mentor Awards to 
twO faculty members: Linda B. Cotder, PhD, and 
Herberr W. Virgin IV, MD, PhD. 
Cotder, professor of psychiatry (epidemiology) 
joined the Washington University faculty in 1990. She 
received her MPH from Boston University School of 
Public Health in 1980 and her PhD from Washington 
University in 1987. 
Virgin is an associate professor in medicine, in 
molecular microbiology and in pathology and immunol­
ogy. He received his MD/PhD from Harvard University 
and joined the Washington University faculty in 1991. 
Outstanding Student 
Researcher 
Third-year medical student Clint Walker 
(center) receives the Alpha Omega Alpha 
(AOA) 2001 Student Research Fellowship 
Award from Scot G. Hickman, M0, (left) 
professor of medicine and president of the 
School of Medicine's AOA chapter. Walker 
was awarded $3,000 in support of his 
research on peripheral nerves. His advisers 
on the project are fellow John Winograd, 
MD, (right) and Susan E. Mackinnon, MD, 
professor and head of the division of plastic 
and reconstructive surgery. 
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International 
cooperation 
William A. Peck, MD, executive vice 
chancellor for medical affairs and 
dean of the School of Medicine, 
welcomes Clifford Nii Boi Tagoe, 
MB, ChB, PhD, dean of the 
University of Ghana Medical School, 
during a recent visit. The two 
medical schools, along with BJC 
International Healthcare Services 
and the Missouri Department of 
Economic Development, discussed 
potential collaboration regarding HIV 
programs in Ghana, Africa. 
Graphic: The HIV virion. 
Neufeld recipient of Rudin glaucoma prize for work in protecting nerve cells 
ARTHUR H. NEUFELD, PHD, the Bernard Becker 
Research Professor of Ophthalmology and Visual 
Sciences at the School of Medicine, has been awarded 
the 2000 Lewis Rudin Prize by the New York Academy 
of Medicine. The Rudin Prize is given annua ll y for 
outstanding glaucoma research published during the 
prevlOus year. 
Neufeld showed that protecring reti nal nerve cells can 
help p revem damage in a chronic model of glaucoma. 
In a 1999 paper in the Proceedings ofthe NationaL 
Academy ofSciences, Neufeld and colleagues reported on 
experiments involving an animal model of glaucoma. 
\X!orking in rats with elevated eye pressure, they were 
able ro prevenr loss of retinal ganglion cells by inhibiting 
the action of an enzyme that makes nitric oxide . 
With co-authors Akira Sawada, MD, and Bernard 
Becker, MD, Neufeld demonstrated that an agem ca lled 
aminoguanidine significanrly limited retinal ganglion cell 
loss. Aminoguanidine inhibits the acriviry of the enzyme 
that makes nitric oxide, called inducible nitric oxide 
synthase (NOS-2). 
G laucoma, a disease in which patienrs first lose 
peripheral and then central vision, affects more than 
3 million adu lts and is the second-leading leading cause 
of irreversib le vision loss in the United States. More than 
G Pulse 
80,000 Americans with glaucom a are legally blind from 
the disease, and it is the No.1 cause of blindness in 
African Americans. 
Neufeld has received many grants from the N ational 
Institutes of Health to suPPOrt hi s research. Currenrly, 
he is principal investigaror on the granr, "Pharmaco­
logical Neuroprotection in 
Glaucoma, " which has been 
helping ro suppOrt his 
research aimed at inhibiting 
NOS-2 in the eye. 
Over the last two 
decades, Neufeld has served 
the Eye Research Institute 
of Retina Foundation in a 
variery of capaci ties, including 
direcror of research. He also 
is a member of the Glaucoma Foundation's Scientific 
Advisory Board. He sits on the editoria l board of the 
JournaL ofOcuLar PharmacoLogy and Therapeutics , and he 
is a longtime member of the Association for Research 
in Vision and Ophthalmology, serving both as a trustee 
and as that group's president in 1984. 
The Rudin Prize was established in 1995 and is 
funded by the Samuel and May Rudin Foundation . 
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Arthur H. Neufeld, Phil 
• 
Rose A. Walker 
New Center for Advanced Medicine 
names Walker, Tucker co-directors 
ROSE A. WALKER AND KIMBERLY TUCKER 
will team up to direct the Center for Advanced Medicine 
(CAM), the new ambulatory care center scheduled 
to open in November 2001. 
Walker will represent the 
School of Medicine, and 
Tucker will represent 
Barnes-Jewish Hospital. 
In her new position, 
WaJker will coordinate clinical 
operations and policies with 
the 14 clinical centers housed 
in the Center for Advanced 
Medicine. She will work with 
Tucker on issues that cross institutional and departmental 
management lines, such as service issues affecting patients. 
As a liaison, she will assist patients or faculty members 
with concerns that arise among departments or between 
the medical school and the hospital. 
Walker, who played a critical role in developing 
the Center for Advanced Medicine, also is director of 
ambulatory operations 
for the Facul ty Practice 
Plan. She formerly worked 
as a nurse clinician and a 
nursing administrator for 
inpatient and ambulatory 
services at Barnes-Jewish 
Hospital and as a physician 
practice administrator for 
the medical school. Kimberly Tucker 
Tucker will coordinate 
the center's operational responsibilities related to Barnes­
Jewish Hospital. She will establish standards of practice 
and care and develop policies and procedures in collabo­
ration with Walker. 
A clinical manager, Tucker has been in management 
at Barnes-Jewish Hospital since 1987. She earned a 
bachelor's degree in nursing from the University of 
Missouri-St. Louis, and she is completing a master's 
degree in nursing from the Jewish Hospital College of 
Nursing and Allied Health. Additionally, Tucker has 
served in leadership roles for the American Association 
of Critical Care Nurses and is a member of the American 
College of Health Care Executives. 
Outlook Summer 2001 
Andrew C. Heath, PhD, professor of psychiatry, left, and Kathleen K. 
Bucholz, PhD, research associateprofessor of psychiatry, talk with 
psychiatry department chair and Samuel B. Guze Professor Charles F. 
Zorumski, M0, at the inaugural symposiumnamed in Guze's honor. 
First Guze Symposium held 
E MISSOURI ALCOHOLISM RESEARCH 
CENTER (MARC) recently hosted the first 
Guze Symposium to discuss the latest in clinical 
practice, research and treatment for alcoholism. 
The Guze Symposium was named in honor of 
the late Samuel B. Guze, MD, a pioneer of the medical 
model of psychiatric illness and in the field of alco­
holism research. His early studies of alcohol use and 
abuse were important in the movement to consider 
alcoholism a disease rather than a character flaw. 
U / ,e joined the faculey in 1951 and later served 
as vice chancc.llor fo r medical affairs and president of 
the Washington University Medical Center from 1971 
to 1989. He also served as head of psychiatry from 
1971 to 1989 and again from 1993 to 1997. 
The symposium featured local and national 
experts on topics such as genetic studies of alcoholism, 
the role of depression and anxiety di~o rders in alco­
holism, treatment for alcoholism and drug abuse, and 
the consequences of alcohol abuse by adolescents. 
Created by a $6.7 million grant from the 
National Institute on Alcohol Abuse and Alcoholism 
(NlAAA) at the National Institutes of Health, the 
MARC is one of 15 NIH-funded alcoholism research 
centers. 
Housed at Washington University, the center 
also involves investigators from Saint Louis University, 
University of Missouri-Columbia, St. Louis and 
Palo Alto CA Veterans Administrations, and the 
Queensland Institute for Medical Research in 
Brisbane, Australia. 
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An age-related disease that 
compromises your most 
critical vision responds to a 
promising new therapy 
by Candace O'Connor 
OR AN OLDER ADULT LIKE DOROTHY BEIMFOHR, 
who loves to read and needs to drive, age-related 
macular degeneration (AMD) is a terrifYing diagnosis . 
"When I first heard that, it really just shook me," she says. 
How would this eye disease-in which abnormal blood 
vessels creep under the center of the retina, leaking blood 
and destroying vision-change her life? Would it curtail 
her pleasant visits to the Mascoutah, Illinois library? 
Would it rob her of the sight of her five grandchildren? 
"When patients lose their center 
of vision, you can't tell by looking at 
them that they are handicapped," 
says Nancy M. Holekamp, MD, 
Above: Dorothy Beimfohr, AMD patient. assistant professor of clinical oph­
thalmology, who treated Beimfohr. 
Facing page: Do you take your percep­ "But they won't recognize you 
tion of a simple grid for granted? because they can't see your face, they 
Patients with macular degeneration have a hard time dialing your phone 
may lose the ability to clearly see number and if you ask them to read 
these lines-and the things they love something, they can't. Consequently, 
in life -even overnight. they lose a lot of their independence." 
8 I Can See Clearly Now 
This disease, the leading cause of 
blindness in people 65 and older, is 
nOt only devastating for patients-
it also is frustrating for their physi­
cians. AMD sufferers, who otherwise 
may be in perfect health, become so 
desperate that they sometimes resort 
to sham treatments in an attempt to 
find a cure. And ophthalmologists, 
armed with few clinical weapons to 
fight the disease, have litde they can 
do to help. 
At the Barnes Retina Institute 
(BRI), a national leader in retinal 
research, Washington University fac­
ulty members are involved in several 
clinical trials that are testing new 
therapies aimed at saving or restor­
ing vision in AMD patients. In fact, 
BRI faculty members have partici­
pated in most of the major trials that 
have taken place over th e past several 
decades. A recent trial that examined 
a new approach (0 treating AMD, 
photodynamic therapy, has shown 
promising results. 
Summer 2001 Outlook 

W nte 
center 
of sigh 
fails 
The center of the retina, called the macula, 
is highly detail-sensitive, allowing you 
to read this page or recognize your friend's 
face. Macular degeneration attacks this 
critical area of vision. 
AM 0 comes in two basic forms. The "dry" 
type is characterized by spots called driisen 
and sometimes by atrophy of the tissue 
layer that underlies the retina . No treatment 
exists for dry AMD, but H is also a milder, 
more slowly progressive disease that only 
accounts for 10 percent of severe vision loss 
among AMD patients. 
"Wet" AMD 
The story is much different with the second, 
"wet" form of the disease, in which blood 
and fluid from abnormal blood vessels leak 
onto sensitive photoreceptors in the macula . 
Among AM 0 patients, this type of the dis­
ease accounts for 90 percent of all severe 
vision loss. Often, this change occurs sud­
denly, without warning. 
It is not yet known exactly why this 
happens. Attempts to link AM 0 to smoking 
or diet have not been successful. It is rare 
in Asian and African-American patients and 
most common in women 60 and older of 
Scandinavian descent. There may be a 
hereditary component to the disease -but 
what stands out is its correlation with age. 
The longer you live, the more likely you are 
to develop it. 
Healthy retina 
Appearance of "age 
spots" call ed driisen 
Macula with wet macular 
degeneration (abnormal 
blood vessels) impedes 
central detail vision 
Searching for 
effective treatment 
"We see thousands of pa tients a yea r 
with macular degeneration; they make 
up at leas t 25 percent of our case­
load," says M. Gilbert G rand, MD, 
professor of cl inical ophthalmology. 
"Th is is a very signi ficant problem, 
and we are continuing ro see more 
of it as the popu lation ages. Among 
the saddes t aspects has been having 
ro tell patien ts that we have limited 
forms of trea tment." 
In the late 1980s and early 
1990s, Washingron University and 
o ther institutions particip ated in 
the Macular Phorocoagulation Study, 
sponsored by the Na tionallnsti(Utes 
of Health, which targeted patients 
wi th wet AMD. The firs t phase of this 
trial focused on pati ents whose blood 
vesse ls had pene trated the macula 
but had not yet reached the fovea, 
its tiny, 500-micron-wide cenrer. 
In the study gro up, clinic ians 
used a conventional, thermal laser 
ro destroy the vessels; in the con tro l 
group, pa tients did not receive laser 
trea tment. T he results showed that 
lase r therapy was effective, but it 
was not a perfect solution. Nearly 
50 percent of the ti me the vessels 
grew back-and the laser was 
dest ruc tive, creat ing a blind spOt 
where it did its work. 
St ill, the results were posit ive 
enough that researchers went fu rth er, 
studying pa tients whose blood ves­
sels had grown inro the fovea. T he 
laser treatment again yielded m ixed 
resu lts. It destroyed the blood vessels 
and stymied their regrowth, but it 
also destroyed the cente r of vision, 
rendering pat ients legally blind . Even 
so, 18 months after trea tment, the 
trea ted pa ti ents were better off than 
the untreated control group. 
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Nancy M, Holekamp, MO, examines the eye of patient Sametta House, 
About the same time, two 
Washington University ophthalmol­
ogists-Matthew A. Thomas, MD, 
of the BRI, and former department 
head Henry]. Kaplan, MD­
pioneered an extraordinary form of 
surgery in which they elevated or 
focally detached the retina, plucked 
out the errant blood vessels, and then 
put the retina back in place. A mul­
ticenter clinical trial cu rren rly in 
progress, with Thomas as national vice 
chairman , is evaluating the success of 
this surgery, but it appears so far that 
it works best in younger patients. 
Other trials are ongoing. A 
national, NIH-sponsored study-the 
Complications of AMD Prevention 
Trial (CAPT)-with Grand as prin­
cipal investigator, is studying the 
use of low-power laser to treat dry 
AMD, which can be a precursor to 
the wet form of the disease. 
BRI physicians also are 
participating in a study of macular 
translocation surgery, developed 
at Johns Hopkins. And they are 
enrolling patients in a trial spon­
sored by Alcon Research , Ltd. , to 
see whether a new compound, 
anecortave acetate, StopS the leakage 
from these abnormal blood vessels. 
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Photodynamic therapy 
may be one answer 
But the latest and most promising 
form of AMD treatment is the 
photodynamic therapy (PDT) that 
Dorothy Beimfohr underwent, in 
which a non-thermal laser targets 
leaky blood vessels. 
Washington University partici­
pated in the clinical trials of PDT, 
which was approved by the FDA in 
April 2000 for one form of AMD. 
Already, BRI physicians use it daily, 
and that usage may soon increase, 
since the FDA is on the verge of 
approving its use in other forms of 
AMD. In addition, PDT has strong 
potential for treating patients with 
other retinal diseases . 
Beimfohr is delighted with the 
Outcome of her PDT treatment . 
While many patients have bilateral 
disease, her left eye has not been 
affected . Bu t the vision in her dis­
eased right eye has improved from 
20-80 to 20-40- enabling her to 
drive once again. 
"PDT is an ingenious idea," says 
Holekamp. "The eye is set up per­
fecdy for this type of novel therapy. 
And it only destroys the abnormal 
blood vessels without hurting the 
retina, which is a huge advantage." 
The treatment is easy, quick 
and painless. The trick is to catch 
patients when they are just begin­
ning to lose vision, since those who 
have had the disease for years -
and have formed retinal scar tissue 
-will not benefit from any cUlTenrly 
available treatment. 
Retina specialists initial1y per­
form a fluorescein angiogram test to 
determine which patients are eligible 
for PDT treatment. 
When Beimfohr came in for 
her PDT treatment, she received a 
I O-minute infusion of photopor­
phyrin dye, Visudyne™, into a vein 
in her arm. The dye coursed through 
all the blood vessels in her body, 
including the abnormal vessels in 
her retina. Then Holekamp shone 
the non-destructive laser at her eye 
for 83 seconds. Throughout the 
procedure , Beimfohr was fully 
awake; afterwards, she only had to 
avoid direct sunlight for five days. 
Following treatment, ophthal­
mologists re test PDT-trea ted patients 
at three-month intervals to deter­
mine whether any regrowth has 
occurred. If it has, they repeat the 
treatment. 
Beimfohr was fortunate - not 
only did the photodynamic therapy 
prevent the abnormal blood vessels 
from returning, her vision actually 
improved. 
In the clinical trial of PDT, 
67 percent of patients who received 
the treatment were stabilized or 
improved by it. Only 16 percent, 
however, had a return of good vision. 
"So it is not the cure that we 
were hoping for," says Holekamp, 
"but it is something else that we 
have to offer patients who otherwise 
have no hope." 0 
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conun ru m 
Heidi Beddingfield, infected with HIV for 
more than 10 years, discusses her health 
with William G, Powderly, MO, clinical 
director of the AIOS Clinical Trials Unit 
(ACTU) at the School of Medicine, 
HEN FIRST DIAGNOSED WITH HIV IN 1990, 
Heidi Beddingfield was a carefree I8-year-old, still 
feeling the invincibility of youth. "I expected I only had 
three years to live, but it didn't bother me," she says. 
"After all, what could I do about it?" 
She was right-there wasn't much that could be done at the 
time. The few available drugs could only be expected to control the 
virus for about a year. Besides-it was too much of a hassle for 
the teenager to deal with grinding up multiple pills every day and 
sticking to a strict regimen. 
In a way, she was lucky. Beddingfield's virus didn't 
Rare up until December, 1995. Overnight, she went 
from feeling invincible to becoming incapacitated 
by a bacterial infection that attacked her brain, a not 
uncommon consequence of an immune system weak­
ened by HIV Fortunately, by that time, scientists 
had just discovered a new way to treat the disease: 
by combining three classes of medication. 
After five weeks on this triple-drug cocktail, 
Beddingfield's viral count decreased drastically; after a couple more 
weeks her virus qualified as "undetectable." Six years later, her AIDS 
is still under control. 
But there's a catch. In 1998, Beddingfield started to dramatically 
lose weight. Her body is wasting away, and doctors now suspect the 
very drugs saving her life are to blame. 
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J / hen the first cocktail component (nucleoside 
analogs, such as AZT) was introduced in 1987, 
scientists were optimistic. But patients with human 
immunodeficiency virus (HIV), the precursor ro 
acquired immunodeficiency syndrome (AIDS), sropped 
responding ro the medication after just one year of 
contlnuous use. 
In the following yea rs, twO new classes of drugs were 
quickly approved by the FDA: non-nucleoside reverse 
transcriptase inhibirors and protease inhibitors. By 1995, 
the FDA recogn ized that combining drugs from these 
three classes crippled the virus' ability ro replicate . The 
resulr: highly active antiretroviral therapy (HAART), 
commonly known as the AIDS drug cock tail. 
Thanks to the cocktail, people with AIDS now are 
living considerably longer and healthier lives than before. 
But the treatment fall s shOrt of physicians' initial expec­
tations. The new drugs 
may be able to control 
" ... the bodythe virus, but they 
cannot eliminate it. 
Resea rchers have thus tokes 
far conceded that 
patients will have to 
...over 
remain on medication 
for the rest of their lives. the course of 
And, as has happened 
with the first cocktail the disease " 
component when taken 
alone, con ti l1UOUS long­
Kevll1 E. Yorosheski , PhD 
term use of the cocktail 
could result in the devel­
opment of drug-resistant strains of the disease, if patients 
don't adhere strictly to the drug regimen. 
The drugs also may not be risk-free, as previously 
thought. As patients like Heidi Beddingfield live longer 
with the disease and spend yea rs taking these drugs, 
new problems arise. 
"Not un til my body started to change did I really 
feel all the rhings AIDS robs you of," says Beddingfield, 
"you r dignity, your self-es teem, your appearance and 
your physical well-being." 
It's that las t quality-physical well-being-that her 
School of Medicine physicians are focusing on. For 14 
years, the university's AIDS Clinical Trials Unit (ACTU), 
part of the largest consortium of AIDS research centers 
in th e world, has been ar the forefront of developing new 
therapies. In 1997, experts here and at other cemers 
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Steven L. Teitelbaum, MD ,with fellows Michael Wang, MD, and Patrick Ross, PhD. 
starred ro notice a dange rous pattern of metabolic 
changes, such as insulin res istance and high cholesterol; 
roday, these changes are found in roughly half of al l 
patients on the cocktail. If these effects, collectively 
termed lipodys trophy, cominue to intensify as expected, 
researchers predict persons taking the cockeail will even­
ruall y experience a marked increase in life-threatening 
complications such as diabetes, heart disease and stroke. 
Patients with lipodystrophy exhibit at least twO of 
the disorder's three main symptoms: insulin resistance, 
the precurso r ro diabetes; high triglycerides or choles­
terol, which often leads to hea rt disease and stroke; and 
a unique pattern of fat distribution. Patients with the 
disease lose fat from their extremities and their faces, 
and they gain fat inside the abdomen itself, instead of 
just below the skin surface and outside the abdominal 
wall, as in normal weight gain. 
-he exact cause of lipodystrophy is unclear. What1 is known is that HIV makes copies of itself which 
then invade other cells. The virus recruits each corrupted 
cell along the way in a pattern of continuous replication . 
As patienrs live longer with the cocktail's help, the virus 
has more time ro wreak havoc. Also, many HIV-positive 
patienrs are co-infected with other diseases such as 
Hepatitis B. As they survive longer, these secondary 
infections also have more time to affect metabolism. 
But neirher of these theo ties fully explains the 
sudden increased incidence of lipodystrophy noted in 
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the past few years, coincident with introduction of the 
third cocktail component, protease inhibitors. 
"We believe that the body takes a series of hits," 
explains Kevin E. Yarasheski, PhD, associate professor 
of medicine, "and that the toxic effects of the anti-HIV 
drugs and infection with HIV accumulate over the 
course of the disease." Scientists propose that protease 
inhibitors in and of themselves do not cause lipodystro­
phy. But, when taken in conjunction with this sequence 
of "hits," they may trigger undesirable physical and 
biochemical changes in the body. 
Researchers at the ACTU decided to take action. 
William C. Powderly, MD, co-director of the division of 
infectious diseases and professor of medicine, assembled 
a team led by himself, Yarasheski and Samuel Klein, MD, 
the Danforth Professor of Medicine and Nutritional 
Science, to investigate this emerging problem. The team 
plans to analyze muscle and fat tissue samples from 
lipodystrophy patients and compare them with samples 
obtained from HIV-infected individuals who are not 
experiencing metabolic changes. They also will examine 
the contribution of protease inhibitors to these metabolic 
changes by carefully altering the components of the 
cocktail in certain individuals experiencing side effects. 
Further insight into the lipodystrophy phenomenon 
may provide new hope for patients infected with HIV 
and for non-infected individuals with diabetes, high 
cholesterol or triglycerides, or abdominal fat. 
"If we determine the mechanisms underlying the 
cause of lipodystrophy in HIV-infected patients, we 
may be able to develop specific therapies for these com­
plications or, even better, help to design drugs that target 
the virus but avoid these effects," says Powderly. "The 
other spin-off is that this is a model system for very 
common disorders, such as d iaberes and high cholesterol, 
in individuals who are not HIV-positive. We can use 
these new drugs to gain a glimpse of metabolic processes 
in normal, healthy individuals that we otherwise might 
not have found." 
Washington Universiry researchers already have 
made the novel discovery that patients who receive the 
drug cocktail are more susceptible to bone softening, 
such as that which occurs in osteoporosis. Steven L. 
Teitelbaum, MD, the Wilma and Roswell Messing 
Professor of Pathology, specializes in the basic science 
aspect of bone research. Already he is using information 
from the ACTO's clinical research to study the effects of 
HIV on bone cells in mice. 
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The School's clinical AIDS care could 
soon stretch from St. louis to Ethiopia 
Washington University School returned from a trip to 
of Medicine not only has one Mehari's home country, 
of the leading AIDS research Ethiopia, where they discussed 
programs, it also serves the plans for a clinic at the 
St. Louis community through University of Addis Ababa. With 
various outreach efforts. funds from organizations such 
One example is the Helena as the World Bank, the United 
Hatch Special Care Center for Nations and the National 
women with HIV, which has Institutes of Health, the team 
become a nationally recognized hopes to establish a center at 
center of excellence for com­ the university where they will 
prehensive HIV care and clini­ mentor Ethiopian physicians 
cal investigations of HIV among and establish a basic AIDS 
women. therapy program. 
Soon, the School of "We're excited about the 
Medicine's influence may reach possibility of setting up a clinic 
as far as Africa, where avail­ which will be a practical help 
ability of the latest medications to people who are in desperate 
and information is still scarce need," says Clifford. "Ever the 
despite the fact that more than academician, I also am eager 
25 million people there are to have the opportunity to 
now infected with HIV. learn more about this infection 
David B. Clifford, M0, in a different cultural popul'a­
and his African research fellow, tion. We're hopeful that it will 
Enawgaw Mehari, M0, recently be a very rewarding project:' 
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Ethiopian artist Afewerk Tekle created "Unity Triptych," internationally 
famous stained-glass windows that confront visitors in the entrance of 
Africa Hall, headquarters of the United Nations Economic Commission for 
Africa, in Addis Ababa, Ethiopia, if~e piece embodies in three panels Africa's 
sorrowful past, present struggles and high aspirations for the future, 
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Ie uring the first five years of living wi th her disease, 
Heidi Beddingfield neglected to take her medications. 
Even with today's improvemenrs in AIDS therapeutics, 
she ingests a grueling regimen of 30 pills a day. Imagine 
how much more difficult it would be to keep up with 
this rigid schedule for patienrs who also are developing 
neurological symptoms such as memory loss or attention 
difficulties. 
Despite treatment advancemenrs, some patients are 
faced with this added challenge. Within days of being 
infected with HIV, the virus spreads into the central 
nervous system (brain and spinal cord) and into periph­
eral nerves. In fact, it is puzzling that only some patients 
experience the effects of nervous system damage. By 
understanding these symptoms and determining how 
and when they arise, researchers hope to improve their 
basic understanding of AJDS and to develop new ways 
ro treat the infected nervous systems. 
Just as in lipodystrophy, some neurological effects of 
HIV may be exacerbated by the roxicity of medications. 
For example, peripheral neuropathy-chronic, disabling 
pain in peripheral nerves such as those in the feet-actu­
ally worsens with treatment of the virus and is estimated 
ro affect at least 30 percent of patients with AIDS. In 
conrrast, the incidence of central nervous system disor­
ders has decreased since the cocktail was introduced, 
from roughly 65 percent ro less than 10 percent. 
"The numbers are down, but it's still a serious prob­
lem, " says David B. Clifford, MD, the Seay Professor 
of Clinical Neuropharmacology in Neurology and vice 
David B. CliHord, MD, left, confers with research fellow Enawgaw Mehari, MD. 
chairman of neurology. "Our main concern is what 
will happen next, because we know this is an area where 
the virus is JUSt waiting to spring back and where our 
therapies are incomplete." 
The central nervous system arguably presents the 
biggest challenge in understanding how to reach the 
virus and halt its destructive effects. Medications have a 
difficult time getting into the brain because of its natural 
protective shield, the blood-brain barrier. Also, scientists 
suspect that HIV attacks the brain and spinal cord in 
a slightly different fashion than the rest of the body. 
Clifford therefore is examining the cerebrospinal 
fluid-fluid that fills the spaces around the spinal cord 
and in the brain-from HIV-positive patients. He plans 
to measure the activity of the virus in the central nervous 
system as cognitive performance changes and hopes 
ro determine the effectiveness of HIV medications in 
penetrating and helping the nervous system. 
Another unique challenge is that brain cells are more 
sensitive to changes in their environment than other cells 
in the body. According 
If H I V i.s 	 to Clifford, cognitive 
decline may result from 
the sheer presence of 
infected immune ceJJs 
that release chemicals 
not normally found in 
the brain environment. 
ollymole .. " His team currently is 
testing a promising drug 
Pablo Tcbas, MD called selegiline that may 
help protect nerve cells. 
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" Because we can't yet eradicate the 
disease, there is a low-grade infection in 
the brains of all patients with HIV," says 
Clifford. "We are concerned that as 
patients live longer, they may be subject 
to an accelerated degenerative disease , 
similar to Alzheimer's." 
Despite these hurdles, one fact 
remains: These drugs save lives. According 
ro Pablo Tebas, MD, medical director 
of the ACTU and assistant professor of 
medicine, "HIV is not a death senrence 
anymore. There is a trade-off in everything 
in life, and medicine is no exception. 
But the benefits of understanding the 
side effects of therapy will be global." 0 
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Colds and cancer are 
different, right? 
But shouldn't the body's 
defensive gatekeeper­
the immune system­
guard against both? 
Research stood in the 
face of common sense­
Z. RECKESS 
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CHI CKEN SOUP may soothe the throat or ca lm an aching tummy, but the immune 
sys tem ultimately is the body's rea l 
hero, scou ring it for danger and 
defending it against suspect cells. 
Bu t what abou t tumor cells? Does 
the immune system also protect 
aga inst these often dead ly enemies? 
For years scientis ts expected it 
did . Bu t studies in the 1970s found 
that "nude" mice - those thought 
to lack immune cel ls called lym pho­
cytes - d id nOt develop more chemi­
cally induced or spontaneous tumors 
than normal m ice. The immune 
sys tem theory was largely abandoned . 
Bu t some researchers contin ued 
to sea rch for a ro le o f the im mu ne 
sys tem in tu mor development, 
determ ined to bridge the gap 
beween immunology and oncology. 
To that end , Robert D. Schreiber, 
PhD, the Alumni Professor of 
Parhology and Imm unology and 
p rofessor o f molecul ar microb iology, 
formed a co llabo rat ion with Lloyd J. 
Old , MD, director and CEO of 
the Ludwig Institute for Cancer 
Research at Memorial Sioan­
Kettering Cancer C enter in New 
York. Schreiber is known fo r his 
research on interferon-gamma (I FNy), 
an important protein in the im mune 
system, while Old is considered 
by many to be the grandfather o f 
tumor immunology. With help 
from a team of School of Medicine 
researchers, the pair h ave determined 
that the immune system does in 
fact appear to protect agains t 
rumor formation . 
Combined wi th mounting 
evidence in the fi eld , it's a discovery 
that could red irect the pu rsuit o f 
ca ncer therapies and our under­
standing o f how the human body 
responds to infecrion. 
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Four key findings: The immune system eliminates s( 
Schreiber's team first examined whether mice lacking lymphocytes 
developed tumors when exposed to a 
chemical carcinogen. To do so, they devel­
oped a strain of mice that definitively 
lacked functional lymphocytes. This was 
accomplished by inactivating a gene found 
in all lymphocytes, RAG2. 
They then injected the chemical car­
cinogen MeA into a group of mice lacking 
RAG2 and into a group of normal mice. 
Only 19 percent of normal mice developed 
tumors, in contrast with 58 percent of 
RAG2-deficient mice. 
In previous studies, the group exam­
ined the effect of MeA on mice lacking 
either the receptor for IFNy or one of 
the proteins required for the receptor to 
function, Stat1. Roughly half of these 
mice also developed tumors. 
In their current study, the researchers 
also generated mice with two disrupted 
genes-the gene for RAG2 and the gene 
The first two findings show that both 
I IFNyand lymphocytes interact with 
one another to protect individuals 
from cancer development. That's the 
good news. 
But there's also bad news. 
Tumors that developed in normal 
mice due to injection of MeA were later 
transplanted into healthy mice. The tumors 
continued to grow. 
Tumors from RAG2-deficient mice 
also were transplanted into healthy mice. 
Eight out of 20 of these were rejected. 
Apparently, the immune systems in 
healthy, carcinogen-free mice were better 
equipped to recognize-and reject-tumor 
cells that developed in RAG2-deficient 
mice (in the absence of a healthy immune 
system) than tumor cells that had devel­
oped in mice with intact lymphocytes. 
for Stat1. When these doubly-deficient 
mice were injected with MeA, 72 percent 
of them developed tumors. Statistically, 
this was not greater than the incidence 
of tumors in mice that lacked just one 
gene or the other. Therefore, the team 
concluded that RAG2 and the IFNy receptor 
have overlapping roles. 
"We think the two are potentially 
part of the same mechanism but represent 
different steps in the process," explains 
Schreiber. "IFNy makes tumor cells 
expose themselves to the immune system. 
After seeing the abnormal proteins in the 
tumor, the Iympilocytes eliminate the 
tumor cells:' 
Lymphocytes and 
IFNy help prevent 
formation of 
chemically induced 
tumors 
Even a healthy immune 
system only catches 
some tumors-those that 
escape detection pose 
a greater threat 
"As a result of protecting the body, 
the immune system paradoxically favors 
the outgrowth of tumors that are less 
likely to be recognized and killed by the 
immune system," Schreiber says. "It's a 
'survival of the fittest' scenario that 
works against the host:' 
His immunoediting theory may explain 
this selective protection. "If immunoediting 
is always occurring, it can have multiple 
outcomes," he explains. "If you're lucky, 
the outcome is protection. But if you're 
unlucky, transformed tumor cells might 
alter themselves so the immune system 
can pick out only a few. The others 
continue growing:' 
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tes some tumor cells, changes the characteristics of others. 

Only some human tumors can be directly blamed on chemical carcino­
gens. Often, tumors develop spontaneously, 
without any apparent trigger. So Schreiber 
and colleagues examined whether lympho­
cytes and Stat1 contribute to the natural 
development of tumors in the absence of 
a carcinogen. 
Again, they studied three groups of 
mice-normal, RAG2-deficient, and those 
deficient in both RltG-2 and-Stall. 
After 15 months, two of 11 nor mal 
mice had noncancerous tumors and the 
rest were tumor-free. On the other hand, 
~ ~:11;;.. 
all 12 RAG2-deficient mice had developed 
tumors, half of which were cancerous. 
, Lymphocytes and 
IFNy help prevent~____-..~ f formation of 
/"I pontaneous 
• 
umor 
, TAP1 can flag tumors 
; making them more 
t "visible" to the 
, ~ immune system 
t 
Some tumors that escape immune detection appear to have low levels of 
a protein called 'fAP1. So the scientists 
added this protein to tumors before trans­
planting them into healthy mice. This, they 
hoped, would trick the immune system 
and allow for easier identification of 
dangerous cells. 
When highly aggressive tumors such 
as those that managed to develop in mice 
with a healthy immune system were 
transplanted into healthy mice, they grew 
in an extremely rapid manner. However, 
when these tumors first were tagged with 
TAP1 before being transplanted, they were 
rejected. 
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Particularly surprising was the fact 
that mice lacking both RAG2 and Statl 
seemed to get very sick very quickly. All 
11 doubly-deficient mice developed tumors 
well before 15 months. Moreover, six devel­
oped cancerous tumors in the mammary 
glands. This type of cancer rarely occurs 
in RAG2-deficient mice or in young mice 
lacking the IFNy receptor. 
At first glance, the higher threat of 
developing spontaneous tumors in doubly­
deficient mice seems to contradict the first 
finding that mice lacking both genes are 
not at a significantly greater risk of devel­
oping chemically induced tumors. But IFNy 
also plays a part in non-immune responses. 
According to Schreiber, "while the roles of 
lymphocytes and IFNy overlap, IFNy also 
might prevent tumor formation via mecha­
nisms not involving the immune system:' 
When tagged tumors were trans­
planted into RAG2-deficient mice, they 
still went unnoticed. Thus, TAP1 facilitated 
tumor detection and elimination only in 
the presence of a healthy immune system. 
"We showed that if a tumor is forced 
to reveal itself to the immune system, 
it often is rejected," Schreiber explains. 
"We think that a tagged tumor could be 
used to train the immune system to reject 
others like it. This is very exciting because 
it indicates that immunotherapy has a 
significant potential use even for the 
treatment of tumors that are altered by 
the immunoediting process:' 
GLOSSARV 
lymphocytes White blood cells (immune cells) 
that detect and kill foreign or diseased cells 
RAG2 Gene found in all lymphocytes 
IFNy Protein produced by lymphocytes that 
helps the immune system 
The first Haw in the evidence against the immune system 
theory was revealed in the mid-1980s, 
when two separate studies found 
that nude mice were not in fact 
completely free of lymphocytes, as 
previously thought. 
Schreiber and others later found 
signs that both lymphocytes and 
IFNy might play important roles in 
tumor preventIon. 
Now, in a paper published in 
the April 26, 2001 issue of the journal 
Nature, Schreiber's team presents the 
first conclusive evidence that lympho­
cytes and IFNy work together to find 
and eliminate tumor cells. 
When a role for the immune 
system in tumor formation was 
proposed decades ago, scien tists 
envisioned a process called immuno­
surveillance. Like a burglar alarm 
that detects intruders, the immune 
system was thought to patrol the 
body, catching cells at the beginning 
of their transformation into suspi­
cious tumor cells. 
In contrast, Schreiber and his 
colleagues propose a new model 
called immunoediting. Like the 
security guard, editors catch errors 
and delete them. They also adjust 
and tweak areas that need smaller 
alterations. According to immuno­
editing, the immune system con­
stantly eliminates certain types of 
tumor cells and also changes the 
characteristics of others. 
"This sheds light on an age­
old controversy and suggests new 
possibilities for cancer therapy," 
says Schreiber. 0 
Stall Protein required for I FNy to function 
TAPl Protein found in low levels in many 
tumors that escape immune system detection 
Doubly-deficient Mice lacking RAG2 
and Stat1 
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Open wide: Huebener's cheerful high five helps relieve the 
office-visit anxieties of children with special health care needs. 
1)0(10; • 
• 
OR MANY CHILDREN, and indeed 
many adults, a dentist's office is a place 
of dread. But in the pastel-colored waiting 
room of Donald V. Huebener, DDS, MS, 
at St. Louis Children's Hospital, the mood is 
upbeat. Kids tryout the miniature chairs and Aip 
through pop-up books. They laugh and chatter 
with their parents as if they were in line for a ride 
at Six Flags rather than waiting to see the dentist. 
One teenager takes a nap in his sear. 
When it is 9-year-old Sean's turn, he goes in 
to greet Huebener with a smile and a handshake. 
His mother, Dee Ann Godlewski, follows watch­
fully. "He's always happy to see Dr. Don," she 
says, "but when the chair leans back, he gets 
nervous. It's only natural, after all he's been 
through." 
Sean was born with 
a cleft lip and palate, and 
has had 18 surgeries in his 
young life. But Huebener, 
professor of plastic and 
reconstructIve surgery 
who supervises the four 
dental residents and two 
assistants in pediatric 
dentistry at Children's, 
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U6ing a double d06e o~ 
medical 6kiLL and candor, 
Donald V. Huebener, DDS, MS, 
provide6 6pecia[-care dentiMry 
brom cradle to "graduation." 
BY DAVID 
LINZEE 
has had plenty of experience putting children at 
ease during his 30 years at Washington University. 
He takes Sean through his checkup step by step, 
explaining what he is about to do and rewarding 
cooperation with compliments. Soon the visit is 
over, and Sean bounds from the chair with a big 
smile. ''I'm done!" he booms. "Thanks!" There 
remains only a visit to the prize drawer, from 
which he selects a "stretchy alien guy." 
Not all of Sean's visits go this smoothly, but 
his strong relationship with Huebener has guided 
him over the rough spots. "Dr. Don is wonderful 
with kids," says Godlewski. "When he explains 
firmly what has to be done, Sean will giddy up. 
But he also has a soft touch when it's needed. " 
A cleft palate can impair a child's hearing, 
speaking and eating. 
Huebener takes time 
with parents, explaining 
what he and other physi­
cians and dentists must 
do to correct problems. 
"At each stage he's told 
me: 'After this procedure 
Sean will get better,' 
and he always does, " 
Godlewski says. 
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Children with serious medical conditions require com­
plex treatment, of which dental care is an important 
component. Unfortunately, it is often the missing com­
ponent, because there are not enough dentists who are 
willing and able to tackle the challenges of caring for a 
special needs child. According to the American Medical 
Association, dental care is the greatest unmet need of 
these children. 
Lisa Burbes could not find a dentist willing to treat 
her infant daughter, Hope, until Huebener stepped in. 
Hope had a congenital heart defect which would require 
" . B~IDGI G HE 
Complex pediatric medical conditions 
require the care of multidisciplinary spe­
cialists, and teamwork is crucial, notes 
Donald V. Huebener, 0OS, MS, with praise 
for his School of Medicine colleagues. 
"While, in general, medicine and denHstry 
have grown up apart and had separate 
schools of education, it's fortunate that 
doctors from both disciplines work together 
very closely at Children's," he says. 
The manifold resources at St. Louis 
Children'S Hospital and Washington University 
make them outstanding facilities for the 
very sick child. The Medical Center's 
Cleft Palate and Craniofacial Deformities 
Institute, which Huebener helped found, 
currently treats more than 2,200 cleft­
palate patients, as well as some 1,800 
children with other head deformities. The 
Institute brings together the many specialists 
needed by these patients, including plastic 
and oral surgeons, otolaryngologists, speech 
pathologists, audiologists, pediatricians, 
pediatric dentists, prosthodontists, ortho­
dontists, nurses and team coordinators. 
Care of cl'eft-palate patients begins 
in infancy. As a plastic surgeon operates to 
join the upper lip, Huebener, professor of 
plastic and reconstructive surgery and of 
pediatrics, custom-tailors an appliance 
22 Smile Doctor 
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similar to a retainer. Inserted in the roof blood won't clot," Huebener explains. "You 
of the mouth, the appliance helps correctly have to be careful even about giving local 
mold and contour the palate. Further proce­ anesthetics, because he may start to bleed 
dures are performed and other appliances from the needle stick:' In such cases, 
installed as the child grows, sheds baby Huebener has to consult with the child's 
teeth and gains permanent teeth. Care pediatric hematologist about building 
usually is completed when the up the appropriate coagulation 
patient reaches the age of factor in the blood before 
19 or 20, and Huebener he goes to work. 
and his colleagues Children with 
mark the occasion psychomotor distur­
with a "graduation" bances, who are 
ceremony. unable to stay still in 
Children with the chair, may require 
other health problems sedation or general 
also require specialized anesthesia, and so may 
care. Achild with epilepsy very young children with 
may have a seizure while extensive caries. CerebralOr. 06r'1 treatsin the dentist's chair, so palsy patients also find it 
Huebener must be ready ~"15tner ."~pp~ difficult to keep still, but 
to prevent him from hurting Huebener has found that(lIst6rner.himself. In addition, some by holding their heads 
drugs children take to control 

seizures affect the central nervous system, 

so he must be careful about the amount 

of local anesthetic given for a procedure. 

For a child with severe hemophilia, a 
loose baby tooth is a potentially dangerous 
problem. "If you just pull the tooth, the child 
may start to hemorrhage, because the 
four surgeries by the time she was 2 years old. She also 
was prone to cavities. Left untreated, they could provide 
a reservoir for contagion that threatened to spread. 
"Dental caries (tooth decay) is an infectious disease," 
Huebener, professor of pediatrics, explains. "Bacteria may 
go through the enamel into the dentin, then into the 
nerve, and enter the bloodstream." If a child has a heart 
defect, the bacteria may lodge there and create problems. 
Hope now is 9 and has not needed surgery in five 
years. But she still requires vigilant dental care, because 
the re-routing of blood flow resulting from surgical COf­
rection also may make the heart vulnerable to bacteria. 
Hope doesn't mind the frequent visits. "She really likes 
D 
gently he often can work on them without 
general anesthetic. 
The complex medical cases he treats 
provide Huebener and his colleagues with 
the opportunity to meet unique professional 
challenges. But it is his deft personal touch 
that allows him to be both doctor and friend 
to his young patients. 
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is tl1eir 9tA.rne." 
- DONAlD y H UEBENE ~, DDS , ~1S 
From the exam chair to the goody drawer, 

Huebener keeps his young patients smiling, 

D r. Don," Burbes explains as Hope selects her prize 
(a ring, as usual). "His whole staff is good with children." 
Infection spreading from dental caries also is a threat 
to children with other medical problems. Before a child 
can receive an o rgan transplant, surgeons require a clean 
bill of oral health from Huebener. The drugs that pre­
vent the immune system from rejecting the transplant 
also lower the body's defenses against bacterial infection. 
Huebener's current patients include three receiving hearts 
and one receiving a double-lung transplant, along with a 
number of children receiving liver and kidney transplal1ts. 
Cancer patients need meticulous dental care before 
and during chemotherapy, a treatment that causes their 
white blood celJ count to go down, thus making them 
vulnerable to infection. Huebener works closely with their 
pediatric oncologists. "Any dental carc- an extraction, 
a filling, even a rou tine cleaning, has to be timed with 
chemotherapy," he explains. 
Huebener sympathizes with parents who come to 
him after a long day of trudging from one specialist's 
office to another. 
"They're overwhelmed with their child's problems, 
and now they're being sent to still another doctor," he says. 
He remembers one mother of a very sick boy who came 
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in feeling exhausted, discouraged and hostile. He sat 
down with her. "I told her, 'I'm here to help you in any 
way 1 can. Your son's problems are my concern.' And as 
we talked, all the negativity went away. Now we're the 
best of friends." 
Huebener believes in being completely honest with 
parents. He spends a lot of time with them, explaining 
their child's condition and discussing treatment options. 
Lisa Burbes, Hope's mother, notes that Huebener has 
spoken several times to her support group for families of 
children with heart defects. 
Relationships with families of cleft-palate patients 
like Sean Godlewski become especially close because the 
course of treatment is long. "1 had a 16-year-old in today 
whom I first saw as a baby," Huebener says. "Over the 
years, you become a friend of the family." Parents call 
frequently, seeking advice not just on medical care but on 
such issues as whether their child with a cleft deformity 
can go out for football or take up a wind instrument. 
(, ETII N(, "A S T THE f EAI< 
Asked the secret of his rapport with his young patients, 
Huebener smiles and replies: "Pediatric dentists are also 
psychologists. Patience is their middle name and good 
buddy is their game." Contrary to popular belief, he 
observes, fear of the dentist is not a normal part of child­
hood. It arises because, all too often, parents wait until 
children have a mouthful of cavities to take them for 
their initial visit. Ideally, dental visits should begin when 
the first baby tooth comes in. "You build a relationship 
of confidence and trust, so that when you do have to give 
them local anesthesia for a filling, it's not the end of the 
world," Huebener says. 
To put the young patient at ease, he talks as he works, 
explaining what he is going to do and why it is necessary. 
In this, he emulates his own fondly remembered child­
hood dentist, who let him play with the "gizmos and 
gadgets" in the office, and who made a dental checkup 
an occasion to look forward to. His interest sparked, 
Huebener went on to attend Washington University 
School of Dental Medicine. The school, which closed in 
1991, had a fine department of pediatric dentistry, says 
Huebener, and it was the chair, Patricia Parsons, DDS, 
who inspired him to make children his life's work. 
"There's always something to look forward to," says 
Huebener, "something I haven't seen before or helped a 
patient with. That's what makes my job so fascinating." 0 
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i T' A MATCH! The annual match day was held on March 22,2001, andNot just 110 of the 123 graduating medical studen 
took part in the National Resident Matching 
Program (NRMP).another day 
One hundred perc nt of the match day 
participants secured a postgraduate uaining 
po irion. Some 57 percent received fir t-year 
residency positions at their first choice 
of institution and 80 percent matched to one 
of their tOP three choices. Eleven tudents 
found positions independent of the NRMP. 
YEEESSSSSSIlI Hyung Kim unbridles his enthusiasm. 
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Richard A. Blath It's the 'little things' in life 
BY RUTH 
BEBERMEYERMaking a difference in the lives of individuals 
a nine-member group with Blath served as president of the 
five offices in the metro­ Washington University Medical 
politan area. The group, Center Alumni Association 
a pioneer in the early use during 1995-96 and as a mem­
of brachytherapy in the ber of the Executive Council 
Midwest for men with for a number of years. He has 
prostate cancer, has treated chaired class reunions and is a 
more than 300 such patients. member of the Eliot Society. 
Before the approxi- Richard A. Blath, MD '71, urologist and surgeon 
mately 500-n1ember medical ............................................................................................................. -,.. 
 A a child, Blath suffered 
T HE "LITTLE THINGS" are the big reasons why Richard A. Blath, MO '71, finds his work very satisfying. Those little things may be grate­
ful words from a patient whose cancer he has removed, 
or a phone call from a couple with fertility problems 
telling him the good news that the wife is pregnant, or 
the appreciation of parents 
whose child's birth defect 
he has corrected. They are 
indications of the difference 
he makes in the lives of 
individuals. His other 
achievements and the lead­
ership roles he fulfills are 
notable, but he views them 
as incidental to caring for 
his patients. 
Blath, a urologist and 
surgeon, is Chief of Staff at 
Christian Hospital NE-NW 
in St. Louis and managing 
partner of St. Louis 
Urological Surgeons, Inc., 
staff at Christian Hospital elected him chief three years 
ago, Blath, a Fellow of the American College of Surgeons, 
chaired the department of surgery there for 10 years. 
During that time, he initiated with Washington University 
School of Medicine a rotation for surgery residents that 
provides a wealth of training in general, vascular and 
trauma surgery. Residents have often rated it among the 
best of their experiences. 
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The success of the residency program prompted 
School of Medicine faculty to ask Blath to arrange a sur­
gery clerkship for third-year medical students, the first 
such rotation at a hospital away from the Medical Center. 
Two students per month participate, and the clerkship is 
so popular that many more apply than can be accepted. 
Blath takes pride and pleas­
ure in helping residents and 
students broaden their educa­
tion. He remembers apprecia­
tively his own teachers during 
studen t and residen t days at 
Washington University. Two 
who particularly inspired him 
were now Professors Emeritus 
Charles Manley, MO, HS '63-'67, 
the first pediatric urologist in 
St. Louis, and Robert Royce, 
MO '42. Blath calls Royce the 
"ultimate professional whose 
clinical skill and bedside manner 
Dr. Blath you strive to emulate." 
A loyal alumnus ever since, 
from asthma and many 
respiratory and ear infections, which required frequent 
visits to his pediatrician, whom he respected greatly. That 
experience influenced him ro choose medicine as his own 
career. He attended Miami University in Ohio, which 
had a cooperative agreement with Washington University 
permitting students to enter medical school after three 
years of undergraduate work. He was inducted into 
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inspired Blath's career. 
Phi Beta Kappa during his third year, and graduated cum 
Laude after completing the first year of medical school. 
After receiving his medical degree in 1971, Blath 
did a general surge ry residency at Vanderbilt University 
and a urology residency at Barnes Hospital, where he was 
chief resident. Then he spent two years as a major in the 
United States Air Force, as chief of the Division of 
Urology at Wright Patterson Air Force Base in Dayton 
OH, and assistant professor of urology at Wright State 
University School of Medicine. Back in St. Louis in 
1978, he joined St. Louis Uro logical Surgeons and has 
been on the staffs at Christian, DePaul and St. Luke's 
hospitals since. H e sees patients of all ages for the gamut 
of urological problems and does a great deal of treatment 
for infertility. H e has been actively involved in RESOLVE 
of St. Louis, a national society that provides education 
and resources to infertile couples. 
A s health care delivery has become more complex and 
.r-l. more third parries are invo lved , Blath devotes more 
time to parti cipation on policy-making bodies where he 
can be an advocate for patients and physicians. He chairs 
the Medical Executi ve Committee at Christian Hospital 
and is one of five representatives from Christian who 
sit on the Board of Directors of BJC. (He is the only 
independent private practice physician on that board .) 
Christian Hospital President Paul Macek comments that 
the hospital is "fortun ate to have someone of Dr. Blath's 
caliber in key leadership positions" and describes him 
as "a trusted adv iso r in dealing with the challenges we 
face." Blath also serves on physician advisory panels 
of several major health insurers, including Blue Cross 
and United Health Care. 
With all this, the best part of Blath's day is "coming 
home to Lorry," his wife , whom he describes as "the cre­
ative one." A gourmet cook, an artist and a writer, she is 
currently working on a "semi-autobiographical" nove l. 
The rabbi who married them in 1969 declared it a 
"marri age made in heaven" because they met in Lambert 
Airport when both were students returning to Miami 
University after the winter holidays. She had visited her 
parents in Amarillo TX, and had to change planes in 
St. Louis, Richard saw her struggling to carry her new 
stereo, went to assist, and they sat together during th e 
fli ght. The rest is family history, which includes a married 
daughter living in Columbus who is the mother of their 
twO grandsons, and a son, an artist li ving in Rhode Island . 
A lover of adventure, Blath once spent hi s vacation 
on a ca ttle drive in Wyoming (as a boy, he wanted to be 
a cowboy) . He has gone whitewater rafting on the Salmon 
River and in Costa Rica, skiing in Aspen and elsewhere. 
Las t year he and Lorry went on safari in Africa, spending 
time in Zimbabwe and Botswana, a trip that allowed 
him to practi ce his considerable 
photographic sk ills, He also plays 
golf "poo rly," and , perhaps to 
assure that he will take time out 
of his busy life to smell the 
prove rbial roses, he grows more 
than 25 varieties in the backya rd . 
Above: Richard A, Blath, MD, instructs 
third-year medical student Caitlin Aveyard, 
Left: While on African safari, Richard and 
Lorry Blath visit breathtaking Victoria Falls 
in Zimbabwe. 
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David Clayson Supporting research for ALS 
Alumnus endows neurology chair 
ALUMNUS DAVID CLAYSON, PHD, has bequearhed 
a professorship in neurology ar Washingwn Universiry in 
Sr. Louis. The chair will bear his name. 
The annOllncemenr was made by Mark S. Wrighwn, 
PhD, chancellor ofWashingwn University, and William 
A. Peck, MD, execurive vice chancellor for medical affairs 
and dean of rhe School of Medicine. 
.-..- .. ,
'... 
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"Dr. Clayson's generous conrriburion w me Depanmenr 
of Neurology demonsrrares his lifelong commirmenr w our 
universiry," says Wrighwn. "We are honored rhar his name 
will be associared wirh Washington Universiry in perperuiry." 
Clayson, who suffered from amyorrophic lareral 
sclerosis (ALS), more commonly called Lou Gehrig's 
disease, died on April 10, 2001. 
"I was impressed by Dr. Clayson's enrhusiasm and 
compassion for orhers in rhe face of his own devasraring 
illness," says Peck. "His dedicarion will help us recruir 
and suppon wp faculry, reinforcing our rradirion of 
excellence in medical research." 
Clayson received his docwrare in psychology from 
rhe College of Am and Sciences in 1963. He esrablished 
rhe professorship w SUppOH scienrisrs whose research is 
relevanr w developing effecrive rrearmenrs of ALS and 
orher neurodegenerarive diseases. 
"I am saddened by Dr. Clayson's rerrible illness 
and dearh, bur grareful for his humaniry and generosiry 
in making rhis wonderful gifr," says Dennis W . 
Choi, MD, PhD, Andrew B. and Grerchen P 
Jones Professor of Neurology and head of 
neurology ar rhe School of Medicine.r 
Clayson was emerirus professor ar rhe Weill 
Medical College of Cornell Universiry where he 
served as a menror, adminisrrawr and researcher 
for more rhan 38 years. He was head and direcwr 
of clinical rraining of psychology in psychiarry ar 
rhe medical college for 25 years. 
Clayson was co-founder and charrer presidenr 
ofThe Associarion of Professors of Psychology in 
Medical Schools, rhe nrsr narionwide organizarion 
of irs kind in rhe Unired Srares and Canada. He 
also had been prominenr in srare and narional 
organizarions for psychology professionals and was a 
cOI1Sulranr ar rhe Memorial Sloan-Kerrering Cancer 
Cenrer and ar The Hospiral for Special Surgery. 
Based on his own research, Clayson wrore exrensively 
on rhe psychological effecrs of orrhopaedic surgery in 
adolescenrs and children. 
The legacy he leaves wirh rhis professorship mirrors 
Clayson's lifelong dedicarion w reaching. He was 
rhe nrsr recipienr of rhe Dean's Award for Liferime 
Achievemenr in Teaching ar Weill Medical College of 
CorneJi Universiry. 
In addirion w his many orher honors, awards and 
prizes, Clayson once nored wirh pleasure rhar a former 
srudenr had named his nrsr son afrer him. In a recenr 
inrerview, Clayson said: "I always rell my srudenrs rhey 
are my purpose and my family." 
Editor's note: Dr. Clayson had the opportunity to review 
and enjoy an earlier version ofthis article a jew days before 
his death. 
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Reunion 2001 awardees (left to right): Robert M. Senior, MD; Frank Vellios, MD; Richard W. 

Hudgens, MD; Alan L. Pearlman, MD; Theodore C. Feierabend, MD ; Herbert T. Abelson, MD. 

EDICAL ALUMNI from 
the Classes of'41, '46, 
'51, '56, '61 , '66, '71, '76, 
'81, '86 and '91 gathered together 
over three fun-filled days, May 
10-12,2001 , to catch up on one 
another's careers and lives, and to 
reminisce about the "good oM days" 
at the School of Medicine. 
Six outstanding alumni/faculty 
were given special awards. Enjoy a 
taste of the weekend's highlights on 
the following pages . 
Distinguished Service Award 
Robert M. Senior, MD, is Dorothy R. and 
Hubert C. Moog Professor of Pulmonary 
Diseases in Medicine and professor of cell 
biology and physiology at the School of 
Medicine. He is highly respected as a 
clinician and teacher and has played an 
important role in the life of the medical 
school and its affiliated hospitals. Senior 
is currently principal investigator of two 
studies funded by the National Heart, 
Lung and Blood Institute. 
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Alumni Achievement Awards 
Herbert T. Abelson, MD'66, is the George 
M. Eisenberg Professor and chairman of 
pediatrics at the University of Chicago 
Pritzker School of Medicine and physician­
in-chief at University of Chicago Children's 
Hospital. He has served on several distin­
guished journals and, in 1997, as the chair­
man of the American Board of Pediatrics. 
Theodore C. Feierabend, MD '51, is 
a retired medical missionary now living in 
Madison WI. He is a member of the board 
of the ecumenical Triangle Community 
Ministry, which serves an area of public 
housing and private low-income housing in 
the city. He has trained physicians in India 
and Afghanistan, and opened a department 
of plastic and reconstructive surgery and a 
bum unit in northern India. 
Frank Vellios, MD '46, is retired 
but continues to serve as a consultant in 
surgical pathology at St. Joseph's Hospital 
in Atlanta. He hetd faculty positions at a 
number of medical schools and served as 
editor-in-chief of the American Journal 
of Clinical Pathology. 
Alumni/Faculty Awards 
Richard W. Hudgens, MD '56, is profes­
sor of psychiatry at the School of Medicine 
and has served the department in a variety 
of capacities. He was the first faculty 
member named Teacher of the Year, an 
award created by the Class of 1966, and 
was among those named Clinical Teacher 
of the Year by the Class of 2001. He has 
regularly served as reunion chairman for 
his class. 
Alan l. Pearlman, MD '61, is profes­
sor of neurology and of cell biology and 
physiology at the School of Medicine and 
is also director of the neurology service 
at St. Louis ConnectCare. He is the 
coursemaster for the second-year course, 
Diseases of the Nervous System, and 
directs the third-year neurology clerkship. 
Students have repeatedly honored his 
teaching by bestowing upon him the 
Distinguished Service Teaching Award, 
Clinical Teacher of the Year, and Professor 
of the Year. He regularly serves as his 
class reunion chairman. 
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Michael Lewis, M 0 '76, and class social 
chair John Milton, M 0 '76, are all 
smiles at the welcoming reception. 
-
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Members of the Class of 1961, from left, Benje 
Boonshaft, MO; Arthur Clements, MD ; Morton Levy, MD; 
Phil Woerner, M D, and David Reisler, MD. 
Dancing the night away, Arthur Schmidt, M D '46, 
and his wife, Joane. 
Dick Hawkins, MD '46, and James Sisk, MD '46, 
catch up at the reunion banquet. 
From left, Walter German, MO '51 ; Lowell Gess, MO '51 , 
and Taney German, NU '50. 
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Richard Hudgens, MD '56, and Stanley Smith, MD '56, 
visit at the welcoming reception , 
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Marvin Levin, M 0, welcomes 
his classmates to the 
class dinner. 
.­
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Joe Moreland, MD, and Cramer Reed, MD, 
both from the Class of 1941, reminisce at 
their class dinner. 
From left, Penny George; Philip George, M 0 '66; 
class social chair Kevin Schaberg, MD '66; 
Tosca Schaberg; Erin Crane; Fay Bisno, and 
David Bisno, M 0 '66. 
~ltEMl£Ml5l£~ wm-n£N 
Oren Conway, M 0 '71 , and. his wife, Rose, 
attend the "Docs Off Duty" program. 
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Class of 2001 president Andy Josephson, 
M 0, speaks at the reunion banquet. 
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"Docs Off Duty" participant 
Alison Stuebe, M 0 '01 , explains 
how she designed on-line study 
guides that are now used at 
the School of Medicine. 
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Robert Anschuetz, M D '76, shares 
a memory at the Class of 1976 dinner. 
Members from the Class of 1961, 
from left, John Balfour, MD; 
Ron Rosenthal, MD, and John Crosson, MD. 
From left, Herb Iknayan, MD '56; Shelia Iknayan; Toni Johnson, 
and Alan Johnson, M D '56, at the welcoming reception. 
J. William Campbell, MD '77, incoming president of WUMCAA, 
accepts the gavel from outgoing president, Thomas Pohlman, M D '76. 
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Krietmeyer, M D '51, takes 
a photo at his class dinner. 
Capturing memories of 
his 50th Reunion, George 
Jill Trice, M D '76, speaks at 
the scientific presentation 
about lupus and her personal 
battle with the disease. 
Betty Knoblock, NUl '51, and Frank Vellios, MD '46, 
enjoy astory told at the Class of 1946 dinner. 
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ISamuel Schechter, MO '41; Norma Bonham, and 
class social chair Vergil Slee, MO '41, at the 
Khorassan Room. 
l 
Pankaj Gore, Ann Tilley, Paula Gerber 

" and' Chris Combs from the Class of 

2001 celebrate at the reunion banquet. 
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From left Marlene Jessurun ; Eric Vaughn, M 0 '91 ; Shona Clay, 
and Carlos Jessurun, MO '91 , visit with William A. Peck, MO, 
dean of the School of Medicine. 
Charles Goldman, M 0 '81 , Tom Prater, M 0 '83, Micki 
Klearman, MO '81 , and Janice Semenkovich, MO '81, 
enjoy hearing from other classmates. 
Peggy Gramates, M 0 '91, Pearl Serota, 

MO '91, and' Harvey Serota, MO & FHS '88, 

at the Class of 1991 dinner. 

YV{]lN<{i 1[)V~$ 
Reunion is a family affair for 
Mandy Ooumit; Aziz Ooumit, 
MO '91, and their son, 
Samser "Sam:' 
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Class Notes

.... , ................... .. ....... , ............................ .. .......... .............. .. ....... ..... ....... ..... .... .... ..... ....... ....... , ................. , ..... ,., .... ...... .......... ............... ... ...... ........... .............. . 

i 
,i 
, 
I. 
i 
I· [ 
I 

I 

I 
I 
I 
I 
S40EImer B. Miller, MD '43, a rerired general surgeon, wrires rhar he is "living 
wirh my wife, judy, and our 16-year-old 
son in rhe middle of a traer of Carolina 
foresr, where I rend five dogs, five cars, 
a goar, a donkey, ducks, geese, er al." 
The Millers live at Pirrsboro NC. 
Russell D. Shelden, MD '49, is 
president of rhe Missouri Senior Golf 
Associarion. He lives in Kansas City. 
S50 Dottie Llewellyn Rodgers, MD '50, has sold her property in Columbia 
MO, and become a Californian. She is 
enjoying being able to garden year-round. 
Her granddaughrer, Sarah Schooler, 
graduared from medical school ar rhe 
University of Virginia in May. 
Godofredo Herzog, M D '57, reti red 
from pracrice in Seprember 2000 and 
now lives in Longboat Key FL, where 
he enjoys beaches, biking and rravel. 
He wrires rhar he is "srill married 
to Eva, and loving ir for the past 44 
years. " The Herzogs have three married 
children and seven grandchildren 
who visir frequentl y. His next project 
is to wrire a memoir and perhaps 
a novel. 
S60 Margaret l. Hayes, MD, HS '66, is retired but keeps involved wirh 
hospiral and medical society affairs in 
Dayton OH. She chairs the Erhics 
Comminee of rhe Monrgomety County 
Medical Society. She says, "I do miss 
delivering babies, bur I don't mi ss 
insurance companies, erc. I've done 
some traveling and learned to play 
bridge. Golf may be next!" 
James McCulley, MD '68, chairman 
of ophthalmology at rhe University of 
Texas Sourhwestern Medical Center, 
has been named to the board of direc­
tors of Readi ng and Radio Resource, a 
Dallas organization devoted to meet­
ing the reading needs of peop le who 
are visually, physically and learning 
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impaired. McCulley direcrs rhe Jean 
H. & John T. Walter jr. Center for 
Research in Age-Relared Macular 
Degenerarion and holds the David 
Bruton] r. Chair in Ophrhalmology. 
laura Wexler, M D '71, has 
S~O been appointed associ­are dean of student 
affairs and admissions at rhe University 
of Cincinnati College of Medicine, 
where she has been since 1987 . She 
was formerly chief of cardiology ar irs 
affiliared Veterans Affairs Medical 
Cenrer and interim chief of the division 
of cardiology at rhe University of 
Cincinnari Medical Center. 
Charles R. Noble, MD, HS '74, retired 
from his solo privare practice of der­
matology on August 31, 2000. He 
lives in Orlando FL. 
Roger Alan Brumback, MD, HS '75, 
on January 1, 2001, became professor 
and chairman of the deparrmenr of 
pathology ar Creighton Universiry 
School of Medicine and St. joseph 
Hospiral in Omaha NE. 
AI Brock King, HA '76, is president of 
Memphis Managed Care Corporation. 
Sanford P. Sher, MD '76, of 
Philadelphia has been busy obtaining a 
state historic marker for Mower 
General Hospital , which was recently 
dedicared. Mower, one of the largesr 
and most innovative hospitals during 
the Civil War, had 3,600 beds and 
rreated more than 20,000 parients 
from every major battle from 
Gettysburg until the end of the war. 
Scott Greenwood, !VI D '77, and Pam 
Freeman, MD '77, live in Orlando FL, 
where he is president of rhe Orlando 
Heart Center and managing partner 
of a 16-member group, and she prac­
tices wi rh Caryn Hasselbring, M D '82. 
Pam recently was chosen as "Best 
Rheumatologisr in Central Florida" by 
Orlando Magazine. 
Charles EHelson, Mil '78, is serving 
rhis year as president of the medical 
staff at Sr. Luke's Hospital in 
Chesterfield MO. He is also chief 
of rhe Section of Plastic Surgery at 
St. Luke's, where he has been in priva te 
practice since 1983. 
80 Scott A. Mirowitz, MD '85, Sbegan a new posirion March 1,2001, as pro­
fessor and chairman of [he depanmel1t 
of radiology at the University of 
Pirrsburgh Medical Center. 
Clifford V. Harding III, MD, PhD '85, 
has been named director of rhe 
Medical Scienrisr Training Program at 
Case Western Reserve University 
School of Medicine in Cleveland. A 
professor of pathology and oncology 
there, Harding has been on the faculty 
since 1993. Hi s research interests are 
in immunology and cell biology, and 
relate to clinical problems in infectious 
diseases. 
S90 Sharon Meyer Schwartz, OT '95, and husband Sreve celebrared daughter 
Alyssa's Ba[ Mitzvah in March. Their 
son, Michael, is a varsi ty soccer and tennis 
player in high school and an aspiring 
cardiologist. They live in Plainview NY. 
NichollVl. Trump lee, MD '95, and 
husband Gabriel are two of three 
pediatricians at the Naval Hospital at 
Naval Air Station in Lemoore CA. 
They enjoy a busy outparienr practice , 
with occasional inpa[ienrs and about 
30 deliveries a month. They have 
"ample opportunity to participare in 
the administrative side of milira ry 
medicine as well." The Lees plan to 
be there another twO years or so and 
would love to hear from c1assma[es 
rraveling rheir way. 
Charles K. lee, MD '97, writes 
thar he married "the love of my life, " 
Nakyung Kim, MD, on June 18, 
2000 , in Chicago, where they live . He 
recently finished his portion of general 
surgery and began his plastic surge ry 
fellowship at the University of Chicago. 
The couple honeymooned in Portugal , 
Korea and Thailand. 
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Carrie Dickinson Salyer, DT '97, 
married Rob Salyer on September 16, 
2000, at Graham Chapel on the 
Washington University campus. She 
is employed by the Hazelwood School 
District Early Childhood Program as 
an occupational therapist. The Salyers 
live in St. Peters MO. 
Jennifer Meko, MD, HS '98, is finish­
ing the last six months of a two-year 
cardiothoracic fellowship at MemoriaJ 
Sloan-Kettering Cancer Center and 
New York Hospital/Cornell in New 
York City and is looking for a position 
as a general thoracic surgeon. She 
writes, "My husband stays home with 
the kids and keeps our lives organized. 
We have had a blast living in New 
York City, but we currently have an 
acute shortage of space in our apart­
ment, so it's time to move on l " 
IN MEMORY 
lloyd Penn, MD '33, died on December 29, 
2000, in San Francisco at the age of 
93. A physician and surgeon, he was 
a charter, life member and Fellow of 
the American Academy of Family 
Physicians. He had been on the staff 
of St. Francis Memorial Hospital since 
1934. During World War II, he served 
as a commander in the U.S. Navy 
Medical Corps. He was active in 
Masonic Lodges, both York and 
Scottish Ri te bodies, for more than 
50 years. An enthusiastic fresh and salt 
water fisherman, he had fished in the 
United States, Mexico, Canada, Egypt, 
New Zealand and China. He was the 
husband of the late Goldie Penn, after 
whose death he married Jean Penn, 
who survives. Other survivors include 
a son, William Lyttleton Penn, and 
three sisters. 
Gladys Johnson Askey Ezell, N U '40, 
died of pneumonia on December 25, 
2000, in Seguin TX at the age of 84. 
During World War II she served in the 
Washington University hospital unit 
in Africa, Italy and France and later 
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did postgraduate work at Columbia 
University in New York. She was 
a nurse and nursing supervisor at 
Veterans Administration hospitals and 
clinics for 27 years. She was the widow 
of Fred Askey and the wife of Howard 
Ezell, whom she married in 1982. 
In addition to her husband, she is 
survived by a son. 
Henry H. Caraco, M[I '41, died in 
California on March 7, 200 I. 
Ernestine Boylan Shugart, NU'46, 
died in Texas on March 25,2001. 
Joe R. Utley, M0 '60, died in 
Spartanburg Sc, on January 15,2001, 
following a long illness. He was 65. A 
cardiothoracic surgeon, he practiced in 
California and Kentucky prior to 
moving to South Carolina in 1983, 
where he was chief of cardiac surgery 
at Spartanburg Regional Medical 
Center until his retirement in 1995. 
In the early '60s he served as a Right 
surgeon in the U.S. Air Force. He 
founded the Cardiothoracic Research 
and Education Foundation for fur­
thering knowledge related to cardio­
pulmonary bypass surgery in 1979. 
An enthusiastic musician, he played 
trumpet with the Spartanburg 
Symphony Orchestra and, with his 
wife, amassed a collection of rare 
brass instruments that resides at 
America's Shrine to Music Museum 
in Vermillion SO, where the Utleys 
established the Joe R. and Joella F. 
Utley Insti tu te for Brass Studies. 
His wife of 44 years, Joella F. Utley, 
MD '67, a radiation oncologist, survives, 
along with a son, a daughter and 
other rei a tives. 
Mary Kay Burgess, DT '69, of St. Louis 
MO, died of cancer on March 13,2000. 
She was 53. 
FACULTY 
Viktor Hamburger, PhD, famed biologist 
and the Edward Mallinckrodt 
Distinguished Universi ty Professor 
Emeritus in Arts & Sciences, died 
Tuesday, June 12, 200 I, in St. Louis 
after a short illness. He was 100. 
Hamburger was considered a gia!1( in 
neurobiology, embryology and the 
study of programmed cell death, and 
often has been referred to as "the 
father of neuroembryology." He 
earned a doctorate from the University 
of Freiburg in 1925. After completing 
postdoctoral studies in Germany, he 
received a Rockefeller Fellowship to 
study for a year with Frank Lillie at 
the University of Chicago in 1932. 
His intended one-year stay in the 
United States became extended indefi­
nitely when he received word that he 
was not welcome to return to Freiburg 
due to Hitler's "cleansing" of German 
universities. Hamburger joined the 
Washington University faculty in 1935 
as assistant professor of zoology. 
Within six years he had advanced to 
full professor and department chair. 
He continued to serve as chair until 
1966 and was appointed the Edward 
Mallinckrodt Distinguished University 
Professor of biology in 1968. He 
assumed emeritus status in 1969 but 
maintained an active, well-funded 
research program until he was well 
into his 80s. 
Hamburger received many honors 
and accolades, including the National 
Medal of Science, the Horwitz Prize, 
the Harrison Award, the Gerard Prize 
and, most recently, the inaugural 
Lifetime Achievement Award from the 
Society for Developmental Biology, 
conferred June 7, 2000. He also was a 
member of the National Academy of 
Sciences and the American Academy 
of Arts and Sciences. Hamburger was 
preceded in death by his wife, Martha 
Fricke Hamburger, in 1965. He is sur­
vived by daugh ters Carola Marte, 
MD, a physician in New Haven CT, 
and Doris Sloan, PhD, professor 
emerita of geology at the University of 
California, Berkeley, and by four 
grandchildren, twO great-grandchil­
dren and a great-great-grandson. 
Alumni & Development 35 
Here's how it works... Sample Rates of Return 
If both you and your spouse are .. ...... ...... age 55 Single Life 
And create a Deferred-Payment Age Age Payments Begin Rates of Return 
Gift Annuity with ........... .... ... ........ ...... $10,000 45 65 20.3% 
50 65 15.3% 
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55 65 11.6% 
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60 65 8.8% 
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~&55 65 Your immediate charitable 
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will be used for a purpose you choose at 
Washington University. 
* Amount of the charitable deduction may vary slightly. 
60 & 60 65 8.3% 
Individuals over age 65 may find an immediate 
Charitable Gift Annuity or a Charitable Remainder 
Unitrust more attractive . 
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Alzheimer's on Stage Members of the 
St. louis Black Repertory Company perfonn "The Eighth 
Day of the Week,· a play about African-American family 
members' struggle to care for their mother, who has 
memory loss and dementia. Sponsored by the School of 
Medicine and ils Alzheimer's Disease Research Center, 
the Alzheimer's Association of St. louis, and the Black 
Rep. the production aimed to increase awareness of 
the disease in the African-American community and to 
educate the public about lis early warning signs. 
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